Meridian Bioscience (VIVO) and Trinity Biotech PLC (TRIB) Critical Contrast

Meridian Bioscience (VIVO) and Trinity Biotech PLC (TRIB) Critical Contrast


Trinity Biotech PLC and Meridian Bioscience are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitabiliy, earnings, institutional ownership, risk and analyst recommendations. Meridian Bioscience pays an annual dividend of $0.50 per share and has a dividend yield of 3.3%.



from Biotech News